Jan Voss
Anknuten till Forskning
E-postadress: jan.voss@ki.se
叠别蝉枚办蝉补诲谤别蝉蝉: Solnav盲gen 9, Biomedicum, 17165 Solna
Postadress: C3 Fysiologi och farmakologi, C3 FyFa Receptorbiologi, 171 77 Stockholm
Artiklar
- Journal article: ACS PHARMACOLOGY AND TRANSLATIONAL SCIENCE. 2023;6(12):1790-1800Voss JH
- Article: ISCIENCE. 2023;26(4):106492Voss JH; Cr眉semann M; Bartling CRO; Kehraus S; Inoue A; K枚nig GM; Str酶mgaard K; M眉ller CE
- Article: PHARMACEUTICS. 2022;15(1):57Voss JH; Al-Hroub H; Gedschold R; Dietrich JM; Gaffal E; Toma M; Kehraus S; K枚nig GM; Brust P; Fleischmann BK; Wenzel D; Deuther-Conrad W; M眉ller CE
- Article: MOLECULES. 2022;27(12):3792Temirak A; Schlegel JG; Voss JH; Vaa脽en VJ; Vielmuth C; Claff T; M眉ller CE
- Article: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 2022;61(22):e202115545Claff T; Klapschinski TA; Tiruttani Subhramanyam UK; Vaa脽en VJ; Schlegel JG; Vielmuth C; Vo脽 JH; Labahn J; M眉ller CE
- Article: ACS PHARMACOLOGY AND TRANSLATIONAL SCIENCE. 2022;5(5):373-386Voss JH; Mahardhika AB; Inoue A; M眉ller CE
- Article: PHARMACOLOGICAL RESEARCH. 2021;173:105880Voss JH; Nagel J; Rafehi M; Guix脿-Gonz谩lez R; Malfacini D; Patt J; Kehraus S; Inoue A; K枚nig GM; Kostenis E; Deupi X; Namasivayam V; M眉ller CE
- Article: JOURNAL OF NATURAL PRODUCTS. 2021;84(7):1941-1953Hanke W; Patt J; Alenfelder J; Voss JH; Zdouc MM; Kehraus S; Kim JB; Gruji膷i膰 GV; Namasivayam V; Reher R; M眉ller CE; Kostenis E; Cr眉semann M; K枚nig GM
- Article: ACS PHARMACOLOGY AND TRANSLATIONAL SCIENCE. 2021;4(2):888-897Schlegel JG; Tahoun M; Seidinger A; Voss JH; Kuschak M; Kehraus S; Schneider M; Matthey M; Fleischmann BK; K枚nig GM; Wenzel D; M眉ller CE
- Article: NATURE COMMUNICATIONS. 2021;12(1):144Hermes C; Richarz R; Wirtz DA; Patt J; Hanke W; Kehraus S; Vo脽 JH; K眉ppers J; Ohbayashi T; Namasivayam V; Alenfelder J; Inoue A; Mergaert P; G眉tschow M; M眉ller CE; Kostenis E; K枚nig GM; Cr眉semann M
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2021;296:100472Patt J; Alenfelder J; Pfeil EM; Voss JH; Merten N; Eryilmaz F; Heycke N; Rick U; Inoue A; Kehraus S; Deupi X; M眉ller CE; K枚nig GM; Cr眉semann M; Kostenis E
- Article: BRITISH JOURNAL OF PHARMACOLOGY. 2020;177(8):1898-1916Kuschak M; Namasivayam V; Rafehi M; Voss JH; Garg J; Schlegel JG; Abdelrahman A; Kehraus S; Reher R; K眉ppers J; Sylvester K; Hinz S; Matthey M; Wenzel D; Fleischmann BK; Pfeifer A; Inoue A; G眉tschow M; K枚nig GM; M眉ller CE
- Article: FRONTIERS IN CHEMISTRY. 2020;8:833Kuschak M; Schlegel JG; Schneider M; Kehraus S; Voss JH; Seidinger A; Matthey M; Wenzel D; Fleischmann BK; K枚nig GM; M眉ller CE
Alla 枚vriga publikationer
- Preprint: RESEARCH SQUARE. 2024Schulte G; Bous J; Kinsolving J; Gr盲tz L; Scharf M; Voss J; Slecuk B; Adebali O
- Review: TRENDS IN PHARMACOLOGICAL SCIENCES. 2024;45(5):419-429Schulte G; Scharf MM; Bous J; Voss JH; Gratz L; Kozielewicz P
- Preprint: RESEARCH SQUARE. 2024Schulte G; Gr盲tz L; Turku A; Kozielewicz P; Bowin C-F; Scharf M; Voss J; Kinsolving J; Shekhani R; Oliva-Vilarnau N; Koolmeister T; K枚rber M; Lauschke V; L枚ber S; Gmeiner P
- Review: CURRENT MEDICINAL CHEMISTRY. 2022;29(42):6359-6378Voss JH; M眉ller CE
Forskningsbidrag
- Deutsche Forschungsgemeinschaft1 January 2023 - 31 December 2025Frizzleds (FZD1-10) belong to the class F of the G protein-coupled receptor (GPCR) superfamily and play a key role in the signal transduction of secreted lipoglycoproteins of the Wingless-Int1 (WNT) family. In embryonal development, WNT signaling governs essential processes such as cellular differentiation, polarization, and migration, while in the adult, WNT signaling is involved in tissue homeostasis. Abnormal WNT and FZD signaling is related to cancer, fibrosis, arthritis, and Alzheimer鈥檚 disease. Upon WNT binding, FZDs pair with their co-receptors low-density lipoprotein receptor-related protein (LRP) 5/6 and initiate the formation of a large protein complex at the membrane, the signalosome. Signalosome formation ultimately leads to stabilization of the transcriptional cofactor 尾-catenin by disruption of the 尾-catenin-destruction complex. Due to the complexity of WNT signaling pathways, many questions remain unanswered on a molecular level, e.g. the stoichiometry of the signalosome or interaction parameters and surfaces between FZDs and their coreceptors. Furthermore, FZDs were shown to exhibit large conformational changes, typical to other GPCRs, upon ligand binding and it is currently not clear, whether and how these FZD dynamics are involved in FZD signaling. The proposed project is divided into three work packages. The first and main objective aims to form a coherent theory of FZDs in WNT signaling by integrating the concepts of signalosome formation and FZD dynamics. To this end, we will develop BRET biosensors to interrogate the protein-protein interactions between FZDs and LRPs in presence and absence of WNTs. For these experiments, we will create CRISPR-Cas9 edited cells lacking endogenous expression of respective proteins. By using additional tools, such as oncogenic FZD mutants, surrogate WNT peptides, conformational biosensors, and positive allosteric FZD modulators, we intend to characterize the FZD-LRP complex formation that initiates signalosome formation and to unravel the role of FZD dynamics in WNT signal transduction. In another work package, we intend to characterize the interaction between FZDs and other WNT-binding co-receptors, such as RO1/2, RYK, and PTK7 with similar methods. These proteins are known to play a role in WNT signaling, but currently, direct evidence for interactions between these proteins and FZDs is lacking due to unsuitable assay readouts. Lastly, we will investigate if FZDs interact with receptor-activity modifying proteins (RAMPs) and whether a possible interaction affects FZD signaling either directly or e.g. by modulating FZD trafficking in the cell.
础苍蝉迟盲濒濒苍颈苍驳补谤
- Postdoktor, Fysiologi och farmakologi, 探花精选, 2025-2025
- Anknuten till Forskning, Fysiologi och farmakologi, 探花精选, 2025-2025
